Evidence map›Paper›PMID 34989948›Full record

ReviewIndian journal of pediatrics2022

Currently Available Inhaled Therapies in Asthma and Advances in Drug Delivery and Devices.

Biju Thomas, Arun Pugalenthi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Asthma: Advances in Management.Indian journal of pediatrics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Biju ThomasDepartment of Pediatric Respiratory Medicine, KK Women's and Children's Hospital, 100 Bukit Timah Road, 229899, Singapore. biju.thomas@singhealth.com.sg.ORCID http://orcid.org/0000-0002-8627-2300
Arun PugalenthiDepartment of Pediatric Respiratory Medicine, KK Women's and Children's Hospital, 100 Bukit Timah Road, 229899, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medications delivered in the inhaled form remains the cornerstone of medical management of asthma. There have been considerable advances in the development of inhaled medications and devices over the past several decades. Clinicians also have access to regularly updated international guidelines for management of asthma. Despite this, a substantial proportion of children with asthma continue to have persistent poor asthma control and considerable morbidity even in well-resourced settings. The wide selection of medications and devices may complicate clinical decision making. The ideal inhaler would be one that the patient can and will use as advised. One cannot overemphasize the importance of medication adherence and a correct inhaler technique in achieving optimal asthma control. Clinicians who manage children with asthma should have a good understanding of inhaled medications and devices commercially available for the management of asthma and this would help them select the right medication and device for the right patient. This review aims to provide an overview of physiologic basis of inhaler therapy, commonly used inhaled therapies, and the advances in the field of inhaler devices including emerging technologies.

Indexed as

Anti-Asthmatic AgentsAsthmaAdministration, InhalationChildDrug Delivery SystemsHumansMedication AdherenceNebulizers and VaporizersAnti-Asthmatic AgentsAdherenceAsthmaInhalerInhaler deviceInhaler technique

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.